Senate, August 10, 2026 -- The committee on Public Health, to whom was referred the petitions (accompanied by bill, Senate, No. 1485) of Joanne M. Comerford, Rebecca L. Rausch, Jason M. Lewis, Julian Cyr and other members of the Senate for legislation to prohibit nonconsensual intimate examinations of anesthetized or unconscious patients; and (accompanied by bill, Senate, No. 1491) of Brendan P. Crighton, Rory McCarthy, James B. Eldridge and Joanne M. Comerford for legislation relative to chaperones for medical exams, report the accompanying bill (Senate, No. 3197).
This bill submits the Department of Public Health's annual report on the Vaccine Purchase Trust Fund for fiscal year 2024 to the Massachusetts General Court. The fund finances the state's universal purchase and distribution system for routine childhood immunizations, ensuring that children under 19 have access to recommended vaccines through their healthcare providers. During the reported period, the fund collected $208 million from health insurance surcharges and spent $138 million on vaccine purchases and registry maintenance. The report details a significant increase in costs driven by the addition of new vaccines for COVID-19 and respiratory syncytial virus, as well as catch-up vaccinations following the pandemic.
Senate, August 20, 2026 -- The committee on Public Health, to whom was referred the petitions (accompanied by bill, Senate, No. 227) of Ryan C. Fattman and Bruce E. Tarr for legislation to expand options for EMT paramedics; (accompanied by bill, Senate, No. 253) of Jason M. Lewis for legislation to modernize licensure of dietitians and nutritionists by creating a Dietetics and Nutrition board; (accompanied by bill, Senate, No. 1493) of John J. Cronin for legislation to improve patient outcomes across the continuum; (accompanied by bill, Senate, No. 1524) of James B. Eldridge for legislation relative to the Massachusetts lead law and promoting equal access to lead-free housing; (accompanied by bill, Senate, No. 1527) of Ryan C. Fattman and Bruce E. Tarr for legislation relative to arbovirus in the Commonwealth; (accompanied by bill, Senate, No. 1544) of Cindy F. Friedman for legislation relative to interpreters for non-English speaking patient in health care facilities; (accompanied by bill, Senate, No. 1558) of Edward J. Kennedy and Colleen M. Garry for legislation to ban the selling of a herbal substance that can produce opioid- and stimulant-like effects; (accompanied by bill, Senate, No. 1574) of Paul W. Mark and Michael D. Brady for legislation to preserve access to hospital services; (accompanied by bill, Senate, No. 1600) of Patrick M. O'Connor for legislation relative to the safety of Autistic and Alzheimer's individuals; (accompanied by bill, Senate, No. 1613) of Jacob R. Oliveira for legislation to provide access to health transportation for vulnerable patients; and (accompanied by bill, Senate, No. 1620) of Michael F. Rush and Rebecca L. Rausch for legislation to protect children from harmful diet pills and muscle-building supplements, report the accompanying Order (Senate, No. 3258).
This bill establishes a PFAS Remediation Trust Fund to finance water treatment, environmental cleanup, and private well testing for residents, primarily using money recovered from manufacturers through legal settlements. It bans the sale of food packaging containing intentionally added PFAS starting in 2028 and prohibits the sale of specific consumer products like cookware, children's items, and textiles with these chemicals by 2029, unless a temporary exemption is granted for unavoidable uses. The legislation also requires industrial facilities to implement best management practices for PFAS discharges and mandates the phase-out of sludge application without site-specific approval. Additionally, it creates a public reporting platform for manufacturers to disclose PFAS content in products and exempts farmers from certain property taxes if their land is taken out of agricultural use due to regulatory actions related to PFAS contamination.
This bill authorizes the Division of Capital Asset Management and Maintenance to use eminent domain to acquire the Norwood hospital property and any adjacent land owned by MPT of Norwood-Steward, LLC. The goal of this acquisition is to ensure public access to healthcare, and the process requires state funding through appropriation. Once the land is taken, control will be transferred to the Department of Public Health, which has the authority to sell or lease the property to a qualified nonprofit hospital operator. The legislation includes an emergency preamble, allowing it to take effect immediately upon enactment.
This bill requires hospitals to offer flu vaccines to all inpatients aged 65 and older before they are discharged. The rule applies annually between October and February, provided the vaccine is available and there are no medical reasons preventing the shot. Hospitals must follow the latest vaccination guidelines set by the Centers for Disease Control and Prevention or the state public health department. The measure directly impacts hospital discharge procedures and ensures that elderly patients receive immunizations while they are still in the facility.
Senate, May 26, 2026 -- The committee on Health Care Financing to whom was referred the petition (accompanied by bill, Senate, No. 889) of Paul W. Mark for legislation relative to single payer healthcare benchmarking and reporting, report the accompanying bill (Senate, No. 3071).
This bill creates a new Vaccine Program Advisory Council to recommend annual funding levels for the state's childhood immunization program. The council will include representatives from public health officials, insurance companies, managed care organizations, employers, and medical societies to ensure diverse input on vaccine costs. Additionally, the legislation requires healthcare providers participating in state immunization programs to be able to choose any FDA-licensed vaccine brand that is recommended by national health authorities, provided such vaccines are available and safe. These provider choice rules aim to maintain clinical flexibility and stabilize vaccine supplies, with full implementation required by July 1, 2026. The bill also establishes a surcharge on payors to fund the purchase, storage, and distribution of these vaccines through a dedicated trust fund.
This bill serves as a formal communication submitting the annual report for the Community Behavioral Health Promotion and Prevention Commission for fiscal year 2026. The document outlines the commission's role in promoting mental health, preventing substance use disorders, and advising the state legislature on evidence-based policies. It details the commission's 23-member structure, which includes government officials, legislative leaders, and representatives from various health and social service organizations. The text also specifies the commission's duties, such as analyzing data, coordinating wellness programs, and making recommendations to reduce public health costs.
This bill establishes a special commission to investigate the public health and safety risks associated with xylazine being mixed with illicit drugs like fentanyl. The commission will review current data and propose specific strategies to address the growing problem of xylazine use in Massachusetts. The findings and recommendations from this study will be compiled into a final report for legislative consideration. The primary focus is on creating actionable solutions to mitigate the dangers posed by this drug additive.
